UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: biologics

Diversity and Inclusion in a scientific context

You have probably already heard of diversity and inclusion, but isn’t this just another management term? No, not this time! I hope I can convince you that there is real magic in inclusion and embracing diversity. I will introduce you to the world of diversity and inclusion, what it looks like in your daily work routine, and how it can help you and your team. I will also provide you with a few tools and ideas on how to improve inclusion within your team.

Read More

Round-Up of Top Biologics News

With new discoveries and developments in Asthma, Diabetes and Cancer, there has been some interesting news to catch up on this month. Take a look at the list below to find out more:

Read More

Biologics Congress Europe – Slide release

Presented at the 4th Biologics & Biosimilars Congress, these free slides are now available to download and share with your colleagues.

Read More

Antibody Drug Conjugates: Bioanalytical Assay Challenges and Strategies

Antibody-drug conjugates (ADCs) combine the high specificity of a monoclonal antibody (mAb) for a target antigen with the highly potent cytotoxic activity of small-molecule drugs. Although the concept behind ADCs is relatively simple, the successful design and development of ADCs is a complex task. Similar to other biotherapeutics, the understanding of Pharmacokinetics (PK), Pharmacodynamics (PD), and Absorption, Distribution, Metabolism, and Excretion (ADME) properties of ADCs is critical for their successful development.

Read More

A Vision for the Second Green Revolution

There is a Second Green Revolution underway that is harnessing precision agriculture, no-till farming practices, biological, rather than chemical crop inputs and other new, innovative tools that improve soil health and water quality.

Read More

Presentation Slide Release: Biologics Discovery and Development

Presented at the 3rd Biologics and Biosimilars Congress, these 3 sets of slides are available to download and share with your colleagues.

Read More

Developing and Manufacturing Innovative Biologics: Obstacles and Opportunities

In this 30 minute presentation, Ralf Schumacher discusses developing and manufacturing biologics. Translating discovery knowledge into process design, technology upgrading and gated development paradigms are explored.

Read More

Assays in clinical trials and pharmacovigilance

Assays are crucial during pre-clinical and clinical trials, and for pharmacovigilance. By this stage, the molecule has already been fully profiled with a mechanism of action, and efficacy and safety are now being assessed in vivo.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive